FDA Approved: APRETUDE — Supplemental Application (ViiV Healthcare Company)

View source ↗

Summary

FDA approved a supplemental application for APRETUDE (cabotegravir) filed by ViiV Healthcare Company, resulting in an updated labeling/indication for the produc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acquired Immunodeficiency Syndrome
• HIV Infection

Drugs mentioned

• APRETUDE (CABOTEGRAVIR)

Snippet

SUPPL AP for APRETUDE (CABOTEGRAVIR)